Oliver Blankenstein

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 6

Top Topics

Sickle Cell Disease

Replacement Therapy

Deep Brain Stimulation

Prognostic Factors

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of medical Internet research

Journal of pharmacokinetics and pharmacodynamics

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Davide Bindellini, Robin Michelet, Linda B S Aulin, Johanna Melin, Uta Neumann, Oliver Blankenstein, Wilhelm Huisinga, Martin J Whitaker, Richard J Ross, Charlotte Kloft
A quantitative modeling framework to understand the physiology of the hypothalamic-pituitary-adrenal axis and interaction with cortisol replacement therapy. Journal of pharmacokinetics and pharmacodynamics (2024)
Viktoria Stachanow, Uta Neumann, Oliver Blankenstein, Nele Alder-Baerens, Davide Bindellini, Peter Hindmarsh, Richard J Ross, Martin J Whitaker, Johanna Melin, Wilhelm Huisinga, Robin Michelet, Charlotte Kloft
Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Viktoria Stachanow, Uta Neumann, Oliver Blankenstein, Nele Alder-Baerens, Davide Bindellini, Peter Hindmarsh, Richard J Ross, Martin J Whitaker, Johanna Melin, Wilhelm Huisinga, Robin Michelet, Charlotte Kloft
Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Viktoria Stachanow, Uta Neumann, Oliver Blankenstein, Nele Alder-Baerens, Davide Bindellini, Peter Hindmarsh, Richard J Ross, Martin J Whitaker, Johanna Melin, Wilhelm Huisinga, Robin Michelet, Charlotte Kloft
Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Lara Lechner, Robert Opitz, Matt J Silver, Philipp M Krabusch, Andrew M Prentice, Martha S Field, Harald Stachelscheid, Elsa Leitão, Christopher Schröder, Valeria Fernandez Vallone, Bernhard Horsthemke, Karl-Heinz Jöckel, Börge Schmidt, Markus Maria Nöthen, Per Hoffmann, Stefan Herms, Patrick W Kleyn, Matthias Megges, Ulrike Blume-Peytavi, Katja Weiss, Knut Mai, Oliver Blankenstein, Benedikt Obermayer, Susanna Wiegand, Peter Kühnen
Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment. Science translational medicine 15 (705) (2023)
Katarina Braune, Mandy Wäldchen, Klemens Raile, Sigrid Hahn, Tebbe Ubben, Susanne Römer, Daniela Hoeber, Nora Johanna Reibel, Michael Launspach, Oliver Blankenstein, Christoph Bührer
Open-Source Technology for Real-Time Continuous Glucose Monitoring in the Neonatal Intensive Care Unit: Case Study in a Neonate With Transient Congenital Hyperinsulinism. Journal of medical Internet research 22 (12) (2020)
Claudia Frömmel, Annemarie Brose, Jeannette Klein, Oliver Blankenstein, Stephan Lobitz
Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants. BioMed research international 2014 (2014)